Related references
Note: Only part of the references are listed.Identification of potential histone deacetylase1 (HDAC1) inhibitors using multistep virtual screening approach including SVM model, pharmacophore modeling, molecular docking and biological evaluation
Shagun Krishna et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2020)
Amyloid β fibril disruption by oleuropein aglycone: long-time molecular dynamics simulation to gain insight into the mechanism of action of this polyphenol from extra virgin olive oil
Simone Brogi et al.
FOOD & FUNCTION (2020)
Insights into structural features of HDAC1 and its selectivity inhibition elucidated by Molecular dynamic simulation and Molecular Docking
Yudibeth Sixto-Lopez et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Homology modeling of human histone deacetylase 10 and design of potential selective inhibitors
Abdullahi Ibrahim Uba et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2019)
Identification of Novel 3-Hydroxy-pyran-4-One Derivatives as Potent HIV-1 Integrase Inhibitors Using in silico Structure-Based Combinatorial Library Design Approach
Hajar Sirous et al.
FRONTIERS IN CHEMISTRY (2019)
An integrated in silico screening strategy for identifying promising disruptors of p53-MDM2 interaction
Hajar Sirous et al.
COMPUTATIONAL BIOLOGY AND CHEMISTRY (2019)
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems
Alessandro Grillo et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synthesis, Molecular odelling and Biological Studies of 3-hydroxypyrane-4-one and 3-hydroxy-nyridine-4-one Derivatives as HIV-1 Integrase Inhibitors
Hajar Sirous et al.
MEDICINAL CHEMISTRY (2019)
Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay
Abdullahi Ibrahim Uba et al.
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS (2018)
Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain
Margherita Brindisi et al.
CHEMMEDCHEM (2018)
Novel spiroindoline HDAC inhibitors: Synthesis, molecular modelling and biological studies
Margherita Brindisi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2018)
Identification of novel fluorescent probes preventing PrPSc replication in prion diseases
Ludovica Zaccagnini et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Design, synthesis and biological evaluation of novel coumarin-based benzamides as potent histone deacetylase inhibitors and anticancer agents
Tooba Abdizadeh et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Why Hydroxamates May Not Be the Best Histone Deacetylase InhibitorsWhat Some May Have Forgotten or Would Rather Forget?
Sida Shen et al.
CHEMMEDCHEM (2016)
A Phase I/II Multicenter, Open-Label Study of the Oral Histone Deacetylase Inhibitor Abexinostat in Relapsed/Refractory Lymphoma
Andrew M. Evens et al.
CLINICAL CANCER RESEARCH (2016)
PubChem Substance and Compound databases
Sunghwan Kim et al.
NUCLEIC ACIDS RESEARCH (2016)
Inside HDACs with more selective HDAC inhibitors
Joelle Roche et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2016)
Phenylpyrrole-based HDAC inhibitors: synthesis, molecular modeling and biological studies
Margherita Brindisi et al.
FUTURE MEDICINAL CHEMISTRY (2016)
Epigenetics: Novel Therapeutics Targeting Epigenetics
Stuart J. Conway et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Harnessing the pyrroloquinoxaline scaffold for FAAH and MAGL interaction: definition of the structural determinants for enzyme inhibition
Margherita Brindisi et al.
RSC ADVANCES (2016)
Role of computer-aided drug design in modern drug discovery
Stephani Joy Y. Macalino et al.
ARCHIVES OF PHARMACAL RESEARCH (2015)
FDA Approval: Belinostat for the Treatment of Patients with Relapsed or Refractory Peripheral T-cell Lymphoma
Hyon-Zu Lee et al.
CLINICAL CANCER RESEARCH (2015)
Panobinostat: First Global Approval
Karly P. Garnock-Jones
DRUGS (2015)
Histone Deacetylase Inhibitors in Clinical Studies as Templates for New Anticancer Agents
Madhusoodanan Mottamal et al.
MOLECULES (2015)
Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders
Katrina J. Falkenberg et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
Chidamide, a novel histone deacetylase inhibitor, synergistically enhances gemcitabine cytotoxicity in pancreatic cancer cells
Zhixin Qiao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy
Guido Finazzi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
3D-QSAR using pharmacophore-based alignment and virtual screening for discovery of novel MCF-7 cell line inhibitors
Simone Brogi et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2013)
Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments
G. Madhavi Sastry et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2013)
Class I HDACs Share a Common Mechanism of Regulation by Inositol Phosphates
Christopher J. Millard et al.
MOLECULAR CELL (2013)
Predicting Pharmacokinetic Profiles Using in Silico Derived Parameters
Natalie A. Hosea et al.
MOLECULAR PHARMACEUTICS (2013)
Computational identification of novel histone deacetylase inhibitors by docking based QSAR
Syam B. Nair et al.
COMPUTERS IN BIOLOGY AND MEDICINE (2012)
Discovery of a novel histone deacetylase 8 inhibitor by virtual screening
Lei Zhang et al.
MEDICINAL CHEMISTRY RESEARCH (2012)
Histone deacetylase inhibitors (HDACIs). Structureuactivity relationships: history and new QSAR perspectives
Eleni Pontiki et al.
MEDICINAL RESEARCH REVIEWS (2012)
Toward isozyme-selective inhibitors of histone deacetylase as therapeutic agents for the treatment of cancer
Sophia N. Ononye et al.
PHARMACEUTICAL PATENT ANALYST (2012)
The FAF-Drugs2 server: a multistep engine to prepare electronic chemical compound collections
David Lagorce et al.
BIOINFORMATICS (2011)
Molecular dynamics simulations and drug discovery
Jacob D. Durrant et al.
BMC BIOLOGY (2011)
Entinostat for treatment of solid tumors and hematologic malignancies
Jeffrey Knipstein et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2011)
Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma
Karen M. VanderMolen et al.
JOURNAL OF ANTIBIOTICS (2011)
Inside HDAC with HDAC inhibitors
Philippe Bertrand
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2010)
Clinical Toxicities of Histone Deacetylase Inhibitors
Srividya Subramanian et al.
PHARMACEUTICALS (2010)
Colon cancer cells maintain low levels of pyruvate to avoid cell death caused by inhibition of HDAC1/HDAC3
Muthusamy Thangaraju et al.
BIOCHEMICAL JOURNAL (2009)
HDAC expression and clinical prognosis in human malignancies
Wilko Weichert
CANCER LETTERS (2009)
Pharmacophore Modeling for Qualitative Prediction of Antiestrogenic Activity
Simone Brogi et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2009)
Epigenetics in cancer: Targeting chromatin modifications
Leigh Ellis et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Predictive QSAR workflow for the in silico identification and screening of novel HDAC inhibitors
Georgia Melagraki et al.
MOLECULAR DIVERSITY (2009)
Recent progress in the biology and physiology of sirtuins
Toren Finkel et al.
NATURE (2009)
Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
Nagma Khan et al.
BIOCHEMICAL JOURNAL (2008)
Improved synthesis of histone deacetylase inhibitors (HDIs) (MS-275 and CI-994) and inhibitory effects of HDIs alone or in combination with RAMBAs or retinoids on growth of human LNCaP prostate cancer cells and tumor xenografts
Lalji K. Gediya et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia
Guillermo Garcia-Manero et al.
BLOOD (2008)
FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects
David Lagorce et al.
BMC BIOINFORMATICS (2008)
Histone deacetylase inhibitors: From bench to clinic
Marielle Paris et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Pharmacophore modeling and virtual screening studies to design some potential histone deacetylase inhibitors as new leads
S. Vadivelan et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2008)
Expression of hypoxia-inducible factor-1α, histone deacetylase 1, and metastasis-associated protein 1 in pancreatic carcinoma
Kotaro Miyake et al.
PANCREAS (2008)
Distinct pharmacological properties of second generation HDAC inhibitors with the benzamide or hydroxamate head group
Thomas Beckers et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Computer-aided drug design: Integration of structure-based and ligand-based approaches in drug design
Philip Prathipati et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Histone deacetylase inhibitors in cancer treatment:: A review of the clinical toxicity and the modulation of gene expression in cancer cells
O. Bruserud et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2007)
Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma, (CTCL)
Madeleine Duvic et al.
BLOOD (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results
Steven L. Dixon et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2006)
Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring
Paul D. Lyne et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Molecular dynamics: Survey of methods for simulating the activity of proteins
Stewart A. Adcock et al.
CHEMICAL REVIEWS (2006)
Novel procedure for modeling ligand/receptor induced fit effects
W Sherman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Use of an induced fit receptor structure in virtual screening
W Sherman et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2006)
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer
S Minucci et al.
NATURE REVIEWS CANCER (2006)
Anticancer activities of histone deacetylase inhibitors
Jessica E. Bolden et al.
NATURE REVIEWS DRUG DISCOVERY (2006)
Physics-based scoring of protein-ligand complexes: Enrichment of known inhibitors in large-scale virtual screening
N Huang et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2006)
Quantitation of HDAC1 mRNA expression in invasive carcinoma of the breast
ZH Zhang et al.
BREAST CANCER RESEARCH AND TREATMENT (2005)
A hierarchical approach to all-atom protein loop prediction
MP Jacobson et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2004)
Upregulation and nuclear recruitment of HDACI in hormone refractory prostate cancer
K Halkidou et al.
PROSTATE (2004)
Molecular evolution of the histone deacetylase family: Functional implications of phylogenetic analysis
IV Gregoretti et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy
RA Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Virtual screening of chemical libraries
BK Shoichet
NATURE (2004)
Towards integrated ADME prediction: past, present and future directions for modelling metabolism by UDP-glucuronosyltransferases
PA Smith et al.
JOURNAL OF MOLECULAR GRAPHICS & MODELLING (2004)
Histone deacetylase inhibitors
TA Miller et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Histone deacetylases (HDACs): characterization of the classical HDAC family
AJM De Ruijter et al.
BIOCHEMICAL JOURNAL (2003)
Identification of novel isoform-selective inhibitors within class I histone deacetylases
ED Hu et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
On the role of the crystal environment in determining protein side-chain conformations
MP Jacobson et al.
JOURNAL OF MOLECULAR BIOLOGY (2002)
A review of protein-small molecule docking methods
RD Taylor et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2002)
Expression profile of histone deacetylase 1 in gastric cancer tissues
JH Choi et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Are free energy calculations useful in practice? A comparison with rapid scoring functions for the p38 MAP kinase protein system
DA Pearlman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2001)
Evaluation and reparametrization of the OPLS-AA force field for proteins via comparison with accurate quantum chemical calculations on peptides
GA Kaminski et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2001)
Deacetylation of p53 modulates its effect on cell growth and apoptosis
JY Luo et al.
NATURE (2000)
Binding of a diverse set of ligands to avidin and streptavidin: An accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models
B Kuhn et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Share Paper
